HARVEY CAPITAL MANAGEMENT INC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1119032 PALM BEACH, FL

Position in HALO

as of Jun 30, 2026 · filed Aug 21, 2026 Compact

Position Value

$11,436,264

+$5,580,786 QoQ

Shares Held

146,113

+61.3% QoQ

Ownership

0.129%

of shares outstanding

% of Portfolio

2.42%

of 13F equity value

Holder Rank

#109

of 664 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

HARVEY CAPITAL MANAGEMENT INC holds $42,449,117 across 7 Biotechnology names. HALO ranks #1 (26.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc. This page	146,113	$11,436,264
2	BBIO	BridgeBio Pharma, Inc.	138,835	$10,340,430
3	JAZZ	Jazz Pharmaceuticals plc	26,913	$6,485,225
4	CYTK	Cytokinetics Inc	68,275	$5,816,347
5	ARGX	Argenx SE	4,346	$4,032,088
6	REGN	Regeneron Pharmaceuticals, Inc.	4,975	$3,102,111
7	ABVX	Abivax S.A.	9,280	$1,236,652

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,436,264	146,113	+61.3%	Shares	Sole	2026-08-21
2026-03-31	$5,855,478	90,600	+60.8%	Shares	Sole	2026-05-11
2025-12-31	$3,791,682	56,340	-2.6%	Shares	Sole	2026-02-17
2025-09-30	$4,240,518	57,820	-10.8%	Shares	Sole	2025-10-31
2025-06-30	$3,371,936	64,820	-56.5%	Shares	Sole	2025-08-14
2025-03-31	$9,518,856	149,175	-19.6%	Shares	Sole	2025-04-30
2024-12-31	$8,865,647	185,435	-0.2%	Shares	Sole	2025-01-29
2024-09-30	$10,638,626	185,860	-0.1%	Shares	Sole	2024-10-29
2024-06-30	$9,741,054	186,040	+2.5%	Shares	Sole	2024-07-22
2024-03-31	$7,383,013	181,490	+13.4%	Shares	Sole	2024-05-10
2023-12-31	$5,917,665	160,110	—	Shares	Sole	2024-01-29
No filing history on record for this holder in this stock.